Initial outcomes data from Cleveland Clinic’s Medical Intensive Liver Unit shows significantly improved survival rates for the first 185 cirrhotic patients managed in the new facility.
Cleveland Clinic investigators have developed a significantly improved endoscopic screening approach to identify signet ring cell carcinoma in patients with hereditary diffuse gastric cancer.
Cleveland Clinic has used endoscopic submucosal dissection since 2013 to treat patients with early-stage gastric and esophageal tumors. Dr. Bhatt, who introduced the technique to the health system, discusses its evolution, clinical application, and the results of new outcomes research.
Patients with inflammatory conditions and concomitant cirrhosis who are treated with tumor necrosis factor inhibitors face heightened risk of serious infections and other complications, according to new Cleveland Clinic research.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
The presence of inflammatory bowel disease conveys increased risk of comorbid nonalcoholic fatty liver disease, nonalcoholic steatohepatitis and nonalcoholic cirrhosis, two new Cleveland Clinic epidemiological studies show.
Miguel Regueiro, MD, Chair of Cleveland Clinic’s Department of Gastroenterology, Hepatology and Nutrition, highlights six can’t-miss DDW presentations by our researchers.